Advances and challenges in the treatment of lung cancer.
Li Y, Yan B, He S.
Biomed Pharmacother. 2023 Dec 31;169:115891. doi: 10.1016/j.biopha.2023.115891. Epub 2023 Nov 16.
Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment.
Alduais Y, Zhang H, Fan F, Chen J, Chen B.
Medicine (Baltimore). 2023 Feb 22;102(8):e32899. doi: 10.1097/MD.0000000000032899.
New promises and challenges in the treatment of advanced non-small-cell lung cancer.
Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, Jänne PA, Peters S, Hirsch FR.
Lancet. 2024 Aug 24;404(10454):803-822. doi: 10.1016/S0140-6736(24)01029-8. Epub 2024 Aug 6.
Cancer Progress and Priorities: Lung Cancer.
Schabath MB, Cote ML.
Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1563-1579. doi: 10.1158/1055-9965.EPI-19-0221.
Update 2020: Management of Non-Small Cell Lung Cancer.
Alexander M, Kim SY, Cheng H.
Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11.
Toward personalized treatment approaches for non-small-cell lung cancer.
Wang M, Herbst RS, Boshoff C.
Nat Med. 2021 Aug;27(8):1345-1356. doi: 10.1038/s41591-021-01450-2. Epub 2021 Aug 12.
Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy.
Patel SA, Weiss J.
Clin Chest Med. 2020 Jun;41(2):237-247. doi: 10.1016/j.ccm.2020.02.010. Epub 2020 Apr 16.
Radiotherapy treatment for lung cancer: Current status and future directions.
Vinod SK, Hau E.
Respirology. 2020 Nov;25 Suppl 2:61-71. doi: 10.1111/resp.13870. Epub 2020 Jun 9.
Lung cancer: Biology and treatment options.
Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P.
Biochim Biophys Acta. 2015 Dec;1856(2):189-210. doi: 10.1016/j.bbcan.2015.08.002. Epub 2015 Aug 19.
Lung cancer: current therapies and new targeted treatments.
Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L.
Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.
